Bridgefront Capital’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,718
Closed -$301K 837
2025
Q1
$301K Buy
+4,718
New +$301K 0.09% 394
2024
Q3
Sell
-2,100
Closed -$332K 704
2024
Q2
$332K Buy
+2,100
New +$332K 0.14% 264
2022
Q4
Sell
-2,072
Closed -$229K 510
2022
Q3
$229K Buy
+2,072
New +$229K 0.23% 197
2021
Q2
Sell
-11,609
Closed -$865K 885
2021
Q1
$865K Buy
+11,609
New +$865K 0.27% 77